[go: up one dir, main page]

DE60023720D1 - Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel - Google Patents

Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Info

Publication number
DE60023720D1
DE60023720D1 DE60023720T DE60023720T DE60023720D1 DE 60023720 D1 DE60023720 D1 DE 60023720D1 DE 60023720 T DE60023720 T DE 60023720T DE 60023720 T DE60023720 T DE 60023720T DE 60023720 D1 DE60023720 D1 DE 60023720D1
Authority
DE
Germany
Prior art keywords
tetrahydrocannabinol
semi
aqueous solvent
delta
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023720T
Other languages
English (en)
Other versions
DE60023720T2 (de
Inventor
M Mcphillips
J Economou
G Dedhiya
Ann Wynne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Pharmaceuticals LLC
Original Assignee
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC
Publication of DE60023720D1 publication Critical patent/DE60023720D1/de
Application granted granted Critical
Publication of DE60023720T2 publication Critical patent/DE60023720T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE60023720T 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel Expired - Lifetime DE60023720T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15002399P 1999-08-20 1999-08-20
US150023P 1999-08-20
PCT/US2000/022495 WO2001013886A1 (en) 1999-08-20 2000-08-15 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent

Publications (2)

Publication Number Publication Date
DE60023720D1 true DE60023720D1 (de) 2005-12-08
DE60023720T2 DE60023720T2 (de) 2006-07-20

Family

ID=22532791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023720T Expired - Lifetime DE60023720T2 (de) 1999-08-20 2000-08-15 Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel

Country Status (14)

Country Link
EP (1) EP1212039B1 (de)
JP (1) JP2003535813A (de)
CN (1) CN1187093C (de)
AT (1) ATE308314T1 (de)
AU (1) AU779324B2 (de)
CA (1) CA2382217A1 (de)
DE (1) DE60023720T2 (de)
DK (1) DK1212039T3 (de)
ES (1) ES2246883T3 (de)
IL (2) IL148241A0 (de)
MX (1) MXPA02001804A (de)
NO (1) NO20020835L (de)
NZ (1) NZ517517A (de)
WO (1) WO2001013886A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747058B1 (en) 1999-08-20 2004-06-08 Unimed Pharmaceuticals, Inc. Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor
US7648696B2 (en) 1999-08-20 2010-01-19 Unimed Pharmaceuticals, Llc Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
GB2361869B (en) * 2000-03-09 2004-09-22 Pharmasol Ltd Sublingual delivery of cannabis
ES2280343T3 (es) 2000-03-09 2007-09-16 Gw Pharma Limited Composiciones farmaceuticas que contienen cannabis.
DK1542657T3 (da) * 2002-08-14 2012-03-05 Gw Pharma Ltd Flydende cannabinoidformuleringer til administration via en slimhinde
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
EP2578561A1 (de) 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Verfahren zur Herstellung von Cannavbidiolderivaten und deren Intermediaten
GB2431105A (en) 2005-10-12 2007-04-18 Gw Pharma Ltd Cannabinoids for the treatment of pulmonary disorders
GB2524469A (en) 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
US9918961B2 (en) 2014-02-19 2018-03-20 Kind Consumer Limited Cannabinoid inhaler and composition therefor
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
NZ726746A (en) * 2014-05-29 2020-08-28 Fresh Cut Dev Llc Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
EP3160445B1 (de) 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi-verwandte produkte und verfahren zur verwendung
CN110200953B (zh) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 大麻素在制备吸入给药药物中的应用
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
DK1212039T3 (da) 2005-12-19
NO20020835D0 (no) 2002-02-20
ES2246883T3 (es) 2006-03-01
HK1056318A1 (en) 2004-02-13
NO20020835L (no) 2002-04-02
AU779324B2 (en) 2005-01-20
CN1420761A (zh) 2003-05-28
EP1212039A1 (de) 2002-06-12
AU6910700A (en) 2001-03-19
IL148241A0 (en) 2002-09-12
WO2001013886A1 (en) 2001-03-01
MXPA02001804A (es) 2004-09-06
CA2382217A1 (en) 2001-03-01
NZ517517A (en) 2004-03-26
ATE308314T1 (de) 2005-11-15
DE60023720T2 (de) 2006-07-20
JP2003535813A (ja) 2003-12-02
IL148241A (en) 2007-02-11
EP1212039B1 (de) 2005-11-02
CN1187093C (zh) 2005-02-02

Similar Documents

Publication Publication Date Title
ATE308314T1 (de) Zusammensetzung für inhalierung enthaltend delta- 9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
US4912124A (en) Antifungal dermatological solution
KR950007858A (ko) 정맥내 주사용 라파마이신 제형
ES2110543T3 (es) Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
FI934000A0 (fi) Nya estrar av bi- och tricykliska aminoalkoholer, deras framstaellning och deras anvaendning i laekemedel
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
DE602004016856D1 (de) Hfc lösungsformulierungen enthaltend ein anticholinergikum
MY101536A (en) Anti-inflammatory and analgesic tape for external use
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
ATE228005T1 (de) Pharmazeutische formulierungen aus corticotropin freisetzenden faktor mit verbesserter stabilitaet in fluessiger form
MXPA06000243A (es) Formulacion farmaceutica liofilizada estable de tetrodotoxina.
KR950008468A (ko) 방향족 카복실산 유도체
ATE129898T1 (de) Cyclosporin enthaltende orale pharmazeutische zusammensetzung sowie verfahren zu deren herstellung.
PE20040303A1 (es) Formulacion parenteral liquida estable de parecoxib
ATE214269T1 (de) Oral anzuwendende flüssige arzneilösung
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
JPS58152808A (ja) 含嗽剤組成物
EP0156508A1 (de) Fungizide Aerosol-Lösung
ATE206048T1 (de) Zur topischen applikation bestimmte diclofenac- lösung
ES8706641A1 (es) Procedimiento para preparar derivados de pirazol y bencimidazol.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: UNIMED PHARMACEUTICALS, INC., MARIETTA, GA., US

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1212039

Country of ref document: EP

Representative=s name: LUTZ WERNER BAURIEGEL, 30173 HANNOVER, DE